<DOC>
	<DOCNO>NCT02784314</DOCNO>
	<brief_summary>In observational cost efficacy study , investigator compare Laparoscopic Radical Prostatectomy ( LRP ) versus Robotic-Assisted Laparoscopic Prostatectomy ( RALP ) . Every cost care include hospitalization relate post operative medical consumption obtain record 5 year follow . Functional result ( continence , potency , quality life ) obtain standardised questionnaire . Carcinologic result estimate Prostate Specific Antigen ( PSA ) relapse salvage treatment . Economic evaluation make estimate direct cost four postoperative year along incremental cost-effectiveness ratio ( ICER ) per successful surgical treatment ( preserve urinary continence erectile function PSA &lt; 0.2 ) .</brief_summary>
	<brief_title>Cost Efficacy Evaluation Robot Assisted Radical Prostatectomy</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Localized prostate cancer Gleason grade ≤ 3 + 4 PSA &lt; 15 ng / mL Stage ≤ T2b Eligible receive laparoscopic radical prostatectomy Candidate bilateral unilateral erectile preservation Patient high risk postoperative progression ( PSA &gt; 15 ng / mL ; grade 5 predominant , clinical radiological stage T3 Presenting erectile dysfunction ( IIEF &lt; 22 ) Past history urinary incontinence ( &gt; grade 1 WHO ) Body mass index &gt; 30</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Clinically localized prostate cancer</keyword>
	<keyword>Robotic-assisted prostatectomy</keyword>
	<keyword>Laparoscopic prostatectomy</keyword>
	<keyword>Erectile function ;</keyword>
	<keyword>Cost efficacy study</keyword>
</DOC>